{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:48:15Z","timestamp":1789645695002,"version":"4.0.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.jhep.2004.04.028","type":"journal-article","created":{"date-parts":[[2004,5,29]],"date-time":"2004-05-29T05:10:20Z","timestamp":1085807420000},"page":"229-234","source":"Crossref","is-referenced-by-count":54,"title":["Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis"],"prefix":"10.1016","volume":"41","author":[{"given":"Laurent","family":"Spahr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emile","family":"Giostra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Bresson-Hadni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rubbia-Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hadengue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2004.04.028_BIB1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1055\/s-2007-1007110","article-title":"Cytokines in alcoholic liver disease","volume":"19","author":"McClain","year":"1999","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2004.04.028_BIB2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S0168-8278(00)80242-1","article-title":"Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease","volume":"32","author":"Parlesak","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","article-title":"Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay","volume":"12","author":"Fukui","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1572-0241.1999.00797.x","article-title":"Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage","volume":"94","author":"Keshavarzian","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB5","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0016-5085(92)91122-K","article-title":"Serum levels of cytokines in chronic liver diseases","volume":"103","author":"Tilg","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.1840130211","article-title":"Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients","volume":"13","author":"Khoruts","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB7","doi-asserted-by":"crossref","first-page":"248S","DOI":"10.1111\/j.1530-0277.1998.tb04011.x","article-title":"Tumor necrosis factor and alcoholic liver disease","volume":"22","author":"McClain","year":"1998","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2004.04.028_BIB8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/alcalc\/37.1.81","article-title":"Concentrations of lipopolysaccharide-binding protein, bactericidal\/permeability-increasing protein, soluble CD14 and plasma lipids in relation to endotoxemia in patients with alcoholic liver disease","volume":"37","author":"Sch\u00e4fer","year":"2002","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB9","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.4049\/jimmunol.168.6.2963","article-title":"Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice","volume":"168","author":"Uesugi","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/jhep.2003.50038","article-title":"Increased lipolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement","volume":"37","author":"Albillos","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1530-0277.2001.tb02207.x","article-title":"Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease","volume":"25","author":"Urbaschek","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2004.04.028_BIB12","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.4049\/jimmunol.166.7.4737","article-title":"Reduced early alcohol-induced liver injury in CD14-deficient mice","volume":"166","author":"Yin","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1530-0277.1990.tb00482.x","article-title":"Plasma tumor necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis","volume":"14","author":"Felver","year":"1990","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2004.04.028_BIB14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0376-8716(95)01130-Q","article-title":"Cytokine levels in acute alcoholic hepatitis: a sequential study","volume":"39","author":"Rodriguez-Rodriguez","year":"1995","journal-title":"Drugs Alcohol Depend"},{"key":"10.1016\/j.jhep.2004.04.028_BIB15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.7326\/0003-4819-112-12-917","article-title":"Increased plasma tumor necrosis factor in severe alcoholic hepatitis","volume":"112","author":"Bird","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2004.04.028_BIB16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0168-8278(02)00230-1","article-title":"Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study","volume":"37","author":"Spahr","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/gast.2000.18160","article-title":"Tumor necrosis factor: biology and therapeutic inhibitors","volume":"119","author":"Papadakis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB19","first-page":"G387","article-title":"Mechanisms of hepatic toxicity: TNF-induced liver injury","volume":"275","author":"Bradham","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB20","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0016-5085(99)70354-9","article-title":"Essential role of tumor necrosis factor \u03b1 in alcohol-induced liver injury in mice","volume":"117","author":"Yin","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB21","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.8171316","article-title":"Unraveling function in the TNF ligand and receptor families","volume":"264","author":"Beutler","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.jhep.2004.04.028_BIB22","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4049\/jimmunol.154.3.1307","article-title":"Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release","volume":"154","author":"Leist","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB23","doi-asserted-by":"crossref","first-page":"9292","DOI":"10.1073\/pnas.88.20.9292","article-title":"The two different receptors for tumor necrosis factor mediate distinct cellular responses","volume":"88","author":"Tartaglia","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2004.04.028_BIB24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0168-8278(98)80227-4","article-title":"Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity","volume":"28","author":"Naveau","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/0016-5085(93)90361-F","article-title":"Tumor necrosis factor \u03b1 and interleukin 6 plasma levels in infected cirrhotic patients","volume":"104","author":"Byl","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB26","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0168-8278(97)80160-2","article-title":"Cytokines and the liver","volume":"27","author":"Simpson","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","article-title":"Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence","volume":"23","author":"Pessione","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2004.04.028_BIB28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2004.04.028_BIB29","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0168-8278(01)00289-6","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH","volume":"36","author":"Mathurin","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB30","first-page":"707","article-title":"Alcoholic liver disease: morphological manifestations. Review by an International Group","volume":"1","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2004.04.028_BIB31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0741-8329(02)00206-9","article-title":"Neutrophilic infiltration in alcoholic hepatitis","volume":"27","author":"Bautista","year":"2002","journal-title":"Alcohol"},{"key":"10.1016\/j.jhep.2004.04.028_BIB32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1053\/jhep.2003.09038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"Mathurin","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/qjmed\/86.10.649","article-title":"Managing severe alcoholic hepatitis complicated by renal failure","volume":"86","author":"Mutimer","year":"1993","journal-title":"Q J Med"},{"key":"10.1016\/j.jhep.2004.04.028_BIB34","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1111\/j.1530-0277.1999.tb04531.x","article-title":"Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group","volume":"23","author":"Fujimoto","year":"1999","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2004.04.028_BIB35","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1002\/hep.1840070628","article-title":"Multivariate survival analysis using Cox's regression model","volume":"7","author":"Christensen","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2004.04.028_BIB36","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1073\/pnas.89.11.4845","article-title":"Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor \u03b1 in vitro and in vivo","volume":"89","author":"Van Zee","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2004.04.028_BIB37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.172.2.599","article-title":"Shedding of tumor necrosis factor receptors by activated human neutrophils","volume":"172","author":"Porteu","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2004.04.028_BIB38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI115891","article-title":"Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia","volume":"90","author":"Spinas","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2004.04.028_BIB39","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1111\/j.1530-0277.2000.tb00012.x","article-title":"Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance","volume":"24","author":"Fujimoto","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2004.04.028_BIB40","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00000441-200302000-00005","article-title":"New indications for treatment of chronic inflammation by TNF-alpha blockade","volume":"325","author":"Reimold","year":"2003","journal-title":"Am J Med Sci"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882780400203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882780400203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T19:21:48Z","timestamp":1682709708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882780400203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S016882780400203X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2004.04.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}